Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 190.12

-2.5%

Dec 30 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (23932)	8/4/1998 9:52:00 PM
From: Machaon	Read Replies (5) of 32384

<< Targretin Phase II trials on breast cancer will be starting soon. Initial results are probably at least a year away. >> It will be interesting to see how this application develops. If Targretin Gel and Capsules get an FDA approval for CTCL; that approval might coincide with the results from the Phase II breast cancer trials. Do you know if positive Phase II trials would provide enough data for the "off label" use of Targretin for breast cancer? On another matter: I just purchased a copy of "The essential Guide to Prescription Drugs". This is a complete and excellent source of information on drugs. The book now lists "OTHER (unlabeled) GENERALLY ACCEPTED USES:". That really surprised me. It also makes for interesting reading. Oh well. Another nasty day for the biotechs. I doubled my position in LGNDW. I really don't want to put any more money into the market, but, the low "option like" price compelled me. Good luck, Bob

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next